Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Chelsea Therapeutics International Ltd.    CHTP   US1634281059

Chelsea Therapeutics International Ltd. is a development stage biopharmaceutical company, which seeks to acquires, develops and commercializes innovative products for the treatment of a variety of human diseases, including central nervous system disorders.The company product includes... 
More about the company
2014 H LUNDBECK A/S : Lundbeck Acquires Chelsea Therapeutics
2014 CHELSEA THERAPEUTICS : Lundbeck Purchases Chelsea Therapeutics International
2014 H LUNDBECK A/S : Lundbeck Buys Chelsea Therapeutics
2014 CHELSEA THERAPEUTICS : Lundbeck Acquires Chelsea Therapeutics International
2014 CHELSEA THERAPEUTICS : Notice of Delisting or Failure to Satisfy a Continued Lis..
2014 CHELSEA THERAPEUTICS : Lundbeck successfully completes tender offer for Chelsea ..
2014 CHELSEA THERAPEUTICS : NORTHERA(TM) Clinical Trial Data Published in Neurology
2014 Chelsea Therapeutics Presents Efficacy and Safety Data for NORTHERA at Intern..
More news
Sector news : Bio Therapeutic Drugs
05/28 MEDIVATION : Names Andrew Powell General Counsel
05/28 ALNYLAM PHARMACEUTICALS : to Webcast Presentations at Upcoming June Investor Con..
05/28 ISIS PHARMACEUTICALS : Webcast Alert: Akcea Therapeutics Conference Call
More sector news : Bio Therapeutic Drugs

Income Statement Evolution
More Financials